Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 2
2011 3
2012 3
2013 4
2014 3
2015 2
2016 5
2017 5
2018 1
2019 3
2020 3
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

32 results
Results by year
Filters applied: . Clear all
Page 1
A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice.
Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L, Chilloux J, Ottman N, Duparc T, Lichtenstein L, Myridakis A, Delzenne NM, Klievink J, Bhattacharjee A, van der Ark KC, Aalvink S, Martinez LO, Dumas ME, Maiter D, Loumaye A, Hermans MP, Thissen JP, Belzer C, de Vos WM, Cani PD. Plovier H, et al. Among authors: duparc t. Nat Med. 2017 Jan;23(1):107-113. doi: 10.1038/nm.4236. Epub 2016 Nov 28. Nat Med. 2017. PMID: 27892954 Free article. Clinical Trial.
Apelin, diabetes, and obesity.
Castan-Laurell I, Dray C, Attané C, Duparc T, Knauf C, Valet P. Castan-Laurell I, et al. Among authors: duparc t. Endocrine. 2011 Aug;40(1):1-9. doi: 10.1007/s12020-011-9507-9. Endocrine. 2011. PMID: 21725702 Review.
Gut microbiota, enteroendocrine functions and metabolism.
Cani PD, Everard A, Duparc T. Cani PD, et al. Among authors: duparc t. Curr Opin Pharmacol. 2013 Dec;13(6):935-40. doi: 10.1016/j.coph.2013.09.008. Epub 2013 Sep 24. Curr Opin Pharmacol. 2013. PMID: 24075718 Review.
Apilimod alters TGFβ signaling pathway and prevents cardiac fibrotic remodeling.
Cinato M, Guitou L, Saidi A, Timotin A, Sperazza E, Duparc T, Zolov SN, Giridharan SSP, Weisman LS, Martinez LO, Roncalli J, Kunduzova O, Tronchere H, Boal F. Cinato M, et al. Among authors: duparc t. Theranostics. 2021 Apr 19;11(13):6491-6506. doi: 10.7150/thno.55821. eCollection 2021. Theranostics. 2021. PMID: 33995670 Free PMC article.
Metabolic and cardiovascular adaptations to an 8-wk lifestyle weight loss intervention in younger and older obese men.
Vion J, Sramkova V, Montastier E, Marquès MA, Caspar-Bauguil S, Duparc T, Martinez LO, Bourlier V, Harant I, Larrouy D, Moussaoui N, Bonnel S, Vindis C, Dray C, Valet P, Saulnier-Blache JS, Schanstra JP, Thalamas C, Viguerie N, Moro C, Langin D. Vion J, et al. Among authors: duparc t. Am J Physiol Endocrinol Metab. 2021 Sep 1;321(3):E325-E337. doi: 10.1152/ajpendo.00109.2021. Epub 2021 Jul 12. Am J Physiol Endocrinol Metab. 2021. PMID: 34250814 Free article. Clinical Trial.
Treatment with PCSK9 inhibitors induces a more anti-atherogenic HDL lipid profile in patients at high cardiovascular risk.
Ingueneau C, Hollstein T, Grenkowitz T, Ruidavets JB, Kassner U, Duparc T, Combes G, Perret B, Genoux A, Schumann F, Bobbert T, Steinhagen-Thiessen E, Martinez LO. Ingueneau C, et al. Among authors: duparc t. Vascul Pharmacol. 2020 Dec;135:106804. doi: 10.1016/j.vph.2020.106804. Epub 2020 Sep 25. Vascul Pharmacol. 2020. PMID: 32987194
32 results